Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Antonio A Nemec"'
Autor:
Michael J. Kerin, Joann B. Sweasy, Robert Pilarski, Zelterman Daniel, Sunitha Nallur, Antonio A Nemec, Karl J. Sweeney, Terri P. McVeigh, Nicola Miller, Joanne B. Weidhaas, Jackie Sadofsky
Publikováno v:
Cancer Research. 75:P6-10
Background: The KRAS-variant is a germ-line, functional microRNA binding site mutation in KRAS that leads to increased risk of premenopausal triple negative breast cancer (TNBC) (1), as well as double primary breast/ovarian cancer in women (2). Evide
Autor:
Joann B. Sweasy, Donatello Telesca, Terri P. McVeigh, Song-Yi Jung, Jackie Sadofsky, Trupti Paranjape, Olivia Kelly, Nicola Miller, Michelle Dookwah, Robert Pilarski, Daniel Zelterman, David Salzman, Frank J. Slack, Elcie Chan, Joanne B. Weidhaas, Antonio A Nemec, Karl J. Sweeney, Sunitha Nallur, Michael J. Kerin
Publikováno v:
Cell cycle (Georgetown, Tex.), vol 14, iss 13
Mcveigh, TP; Jung, SY; Kerin, MJ; Salzman, DW; Nallur, S; Nemec, AA; et al.(2015). Estrogen withdrawal, increased breast cancer risk and the KRAS-variant. Cell Cycle, 14(13), 2091-2099. doi: 10.1080/15384101.2015.1041694. UCLA: Retrieved from: http://www.escholarship.org/uc/item/5jd1v0s7
Cell Cycle
Mcveigh, TP; Jung, SY; Kerin, MJ; Salzman, DW; Nallur, S; Nemec, AA; et al.(2015). Estrogen withdrawal, increased breast cancer risk and the KRAS-variant. Cell Cycle, 14(13), 2091-2099. doi: 10.1080/15384101.2015.1041694. UCLA: Retrieved from: http://www.escholarship.org/uc/item/5jd1v0s7
Cell Cycle
© 2015 Taylor & Francis Group, LLC. The KRAS-variant is a biologically functional, microRNA binding site variant, which predicts increased cancer risk especially for women. Because external exposures, such as chemotherapy, differentially impact the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aac3ec3617a2273895595c58d7ccd1c
https://escholarship.org/uc/item/5jd1v0s7
https://escholarship.org/uc/item/5jd1v0s7